University of Chicago: COVID-19 trials

The registry lists 13 COVID-19 studies with University of Chicago as lead sponsor. 3 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 2Phase 2 2Phase 4 1No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dysbiosis & Long COVIDRecruitingNCT06825819
• Dime La VerDAD: Verify, Debunk, and DisseminateRecruitingNCT06417762Not applicable
• A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 InfectionRecruitingNCT06008860Phase 4
• Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved CommunitiesCompletedNCT05500274Not applicableResults posted
• Low vs. Moderate to High Dose Vitamin D for Prevention of COVID-19CompletedNCT04868903Not applicableResults posted
• Community Network-driven COVID-19 Testing and Vaccination of Vulnerable Populations in the Central USCompletedNCT04743908Not applicableResults posted
• Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19TerminatedNCT04479358Phase 2Results posted
• COVID-19 Convalescent PlasmaCompletedNCT04340050Early Phase 1Results posted
• Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 PneumonitisCompletedNCT04331795Phase 2Results posted
• Can Vitamin D Reduce the Burden of COVID-19?CompletedNCT07128069Not applicable
• Leflunomide in Mild COVID-19 PatientsTerminatedNCT04361214Phase 1
• Long Term Outcomes of Patients With COVID-19Active, not recruitingNCT04360538
• High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19CompletedNCT04351620Phase 1